Patents by Inventor Xiaoya MA

Xiaoya MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260219107
    Abstract: A self-referencing spectral constraint-based spectral reconstruction method and apparatus, a device, and a medium are provided. The method includes: acquiring a total transmission matrix through a calibration; acquiring each observed speckle generated after target light passes through each filtering interval of a spectral filter to enter a scattering medium, where all observed speckles form a total observed speckle; forming a self-referencing spectrum based on total intensities of each observed speckle; and constructing a spectral reconstruction model based on a neural network and a physical forward process of the total transmission matrix, constructing a composite loss function based on a speckle intensity estimation error and a self-referencing spectrum error, and optimizing the parameters of the neural network via the composite loss function until convergence, thereby yielding an optimized neural network for spectral reconstruction for a given total observed speckle.
    Type: Application
    Filed: July 16, 2025
    Publication date: July 30, 2026
    Applicant: NATIONAL UNIVERSITY OF DEFENSE TECHNOLOGY
    Inventors: Jiangming XU, Junrui LIANG, Zhongming HUANG, Jun LI, Jun YE, Yanzhao KE, Min JIANG, Yidong GUO, Junhong HE, Xiaoya MA, Yang ZHANG, Man JIANG, Tianfu YAO, Yue TAO, Can LI, Jian WU, Jinyong LENG, Pu ZHOU
  • Patent number: 12227574
    Abstract: The present application provides tumor microenvironment acidity activated anti-CD3 constructs that bind to CD3 (e.g., anti-CD3 monoclonal and multispecific antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-CD3, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-CD3 construct, pharmaceutical compositions containing the anti-CD3 construct, and methods of using the anti-CD3 construct or compositions.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: February 18, 2025
    Assignee: AMBERSTONE BIOSCIENCES, INC.
    Inventors: Yonglei Shang, Aude I. Segaliny, Xiaoya Ma, Xianzhi Jiang, George Wu
  • Publication number: 20240279334
    Abstract: The present application provides tumor microenvironment acidity activated anti-CD3 constructs that bind to CD3 (e.g., anti-CD3 monoclonal and multispecific antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-CD3, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-CD3 construct, pharmaceutical compositions containing the anti-CD3 construct, and methods of using the anti-CD3 construct or compositions.
    Type: Application
    Filed: June 16, 2022
    Publication date: August 22, 2024
    Inventors: Yonglei SHANG, Aude I. SEGALINY, Xiaoya MA, Xianzhi JIANG, George WU